लोड हो रहा है...
Eculizumab in secondary atypical haemolytic uraemic syndrome
Background. Complement dysregulation occurs in thrombotic microangiopathies (TMAs) other than primary atypical haemolytic uraemic syndrome (aHUS). A few of these patients have been reported previously to be successfully treated with eculizumab. Methods. We identified 29 patients with so-called secon...
में बचाया:
| में प्रकाशित: | Nephrol Dial Transplant |
|---|---|
| मुख्य लेखकों: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Oxford University Press
2017
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5410989/ https://ncbi.nlm.nih.gov/pubmed/28339660 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfw453 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|